Timothy R. Sterling

Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies

The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study

Care interruptions and mortality among adults in Europe and North America

Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies

Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis

Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response

Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa

CD4/CD8 Ratio and Cancer Risk Among Adults With HIV

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment

Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study

Elevated Plasma Matrix Metalloproteinase 8 Associates With Sputum Culture Positivity in Pulmonary Tuberculosis

High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high <scp>HIV</scp> prevalence

Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015

Risk of HCC With Hepatitis B Viremia Among HIV/HBV‐Coinfected Persons in North America

Mortality Among Persons Entering HIV Care Compared With the General U.S. Population

Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020

Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada

RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response

Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor–Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada

Guidelines for the treatment of latent tuberculosis infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020

Latent Tuberculosis Infection and Subclinical Coronary Atherosclerosis in Peru and Uganda

Hospitalization Rates and Causes Among Persons With HIV in the United States and Canada, 2005–2015

Timing of Antiretroviral Therapy Initiation and Risk of Cancer Among Persons Living With Human Immunodeficiency Virus

Effects of Pregnancy and Isoniazid Preventive Therapy on<i>Mycobacterium tuberculosis</i>Interferon Gamma Response Assays in Women With HIV

Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies

Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women

Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study

Differential Expression of Activation Markers by <i>Mycobacterium tuberculosis</i>-specific CD4+ T Cell Distinguishes Extrapulmonary From Pulmonary Tuberculosis and Latent Infection

Association of Immunosuppression and Human Immunodeficiency Virus (HIV) Viremia With Anal Cancer Risk in Persons Living With HIV in the United States and Canada

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis